Emily Field
Stock Analyst at Barclays
(2.92)
# 2,580
Out of 4,339 analysts
806
Total ratings
45.2%
Success rate
1.5%
Average return
Main Sectors:
Stocks Rated by Emily Field
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintained: Buy | $1,400 | $1,064.74 | +31.49% | 12 | May 26, 2026 | |
| BIIB Biogen | Reiterated: Hold | $185 | $193.08 | -4.18% | 5 | May 14, 2026 | |
| AMGN Amgen | Maintained: Hold | $350 | $335.94 | +4.19% | 6 | May 5, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Buy | $75 | $58.03 | +29.24% | 5 | May 1, 2026 | |
| MRK Merck & Co. | Maintained: Buy | $140 | $119.72 | +16.94% | 6 | May 1, 2026 | |
| ABBV AbbVie | Maintained: Buy | $275 | $213.12 | +29.04% | 6 | Apr 28, 2026 | |
| GILD Gilead Sciences | Maintained: Hold | $155 | $133.73 | +15.91% | 3 | Apr 21, 2026 | |
| PFE Pfizer | Maintained: Sell | $25 | $25.85 | -3.29% | 2 | Apr 21, 2026 | |
| CYTK Cytokinetics | Rated: Buy | $95 | $76.29 | +24.52% | 7 | Apr 6, 2026 | |
| GSK GSK plc | Downgraded: Sell | n/a | $51.50 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $150.80 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $44.15 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $52.57 | - | 1 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 275.00 | $331.20 | -16.97% | 59 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 1,450p | $1,925.00 | -24.68% | 126 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €115.00 → €105.00 | $76.32 | +37.58% | 37 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 46.50 → CHF 55.00 | $64.78 | -15.10% | 9 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 700.00 → kr 375.00 | $288.35 | +30.05% | 54 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 14,000p | $13,960.00 | +0.29% | 78 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €22.00 | $23.84 | -7.72% | 32 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | CHF 90.00 | $118.44 | -24.01% | 44 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €25.00 | $37.82 | -33.90% | 59 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 2,000p | $1,480.00 | n/a | 61 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 2,100 | $1,723.63 | n/a | 45 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €195.00 | $128.35 | n/a | 74 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €390.00 → €430.00 | $699.70 | n/a | 21 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €8.00 → €9.00 | $9.61 | n/a | 4 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €75.00 | $161.40 | n/a | 22 | Nov 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €125.00 → €90.00 | $243.60 | n/a | 14 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $145 → $125 | $27.64 | n/a | 7 | Jan 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $52.84 | $18.76 | n/a | 1 | Aug 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $0.00001 | n/a | 1 | Apr 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $8.02 | n/a | 2 | Jun 1, 2018 |
Eli Lilly and Company
May 26, 2026
Maintained: Buy
Price Target: $1,400
Current: $1,064.74
Upside: +31.49%
Biogen
May 14, 2026
Reiterated: Hold
Price Target: $185
Current: $193.08
Upside: -4.18%
Amgen
May 5, 2026
Maintained: Hold
Price Target: $350
Current: $335.94
Upside: +4.19%
Bristol-Myers Squibb Company
May 1, 2026
Maintained: Buy
Price Target: $75
Current: $58.03
Upside: +29.24%
Merck & Co.
May 1, 2026
Maintained: Buy
Price Target: $140
Current: $119.72
Upside: +16.94%
AbbVie
Apr 28, 2026
Maintained: Buy
Price Target: $275
Current: $213.12
Upside: +29.04%
Gilead Sciences
Apr 21, 2026
Maintained: Hold
Price Target: $155
Current: $133.73
Upside: +15.91%
Pfizer
Apr 21, 2026
Maintained: Sell
Price Target: $25
Current: $25.85
Upside: -3.29%
Cytokinetics
Apr 6, 2026
Rated: Buy
Price Target: $95
Current: $76.29
Upside: +24.52%
GSK plc
Jan 6, 2026
Downgraded: Sell
Price Target: n/a
Current: $51.50
Upside: -
Jan 6, 2026
Upgraded: Hold
Price Target: n/a
Current: $150.80
Upside: -
Jan 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $44.15
Upside: -
Jan 6, 2026
Upgraded: Buy
Price Target: n/a
Current: $52.57
Upside: -
Sep 24, 2025
Maintained: Hold
Price Target: CHF 275.00
Current: $331.20
Upside: -16.97%
Aug 12, 2025
Maintained: Hold
Price Target: 1,450p
Current: $1,925.00
Upside: -24.68%
Aug 12, 2025
Maintained: Buy
Price Target: €115.00 → €105.00
Current: $76.32
Upside: +37.58%
Aug 8, 2025
Maintained: Buy
Price Target: CHF 46.50 → CHF 55.00
Current: $64.78
Upside: -15.10%
Aug 4, 2025
Maintained: Hold
Price Target: kr 700.00 → kr 375.00
Current: $288.35
Upside: +30.05%
Jul 30, 2025
Maintained: Buy
Price Target: 14,000p
Current: $13,960.00
Upside: +0.29%
Jul 29, 2025
Maintained: Sell
Price Target: €22.00
Current: $23.84
Upside: -7.72%
Jul 21, 2025
Maintained: Sell
Price Target: CHF 90.00
Current: $118.44
Upside: -24.01%
Jun 27, 2025
Maintained: Hold
Price Target: €25.00
Current: $37.82
Upside: -33.90%
Apr 25, 2025
Maintained: Hold
Price Target: 2,000p
Current: $1,480.00
Upside: n/a
Apr 15, 2025
Maintained: Buy
Price Target: kr 2,100
Current: $1,723.63
Upside: n/a
Oct 29, 2024
Maintained: Buy
Price Target: €195.00
Current: $128.35
Upside: n/a
Jun 21, 2023
Maintained: Buy
Price Target: €390.00 → €430.00
Current: $699.70
Upside: n/a
Nov 21, 2022
Maintained: Sell
Price Target: €8.00 → €9.00
Current: $9.61
Upside: n/a
Nov 25, 2021
Maintained: Sell
Price Target: €75.00
Current: $161.40
Upside: n/a
Oct 15, 2021
Downgraded: Hold
Price Target: €125.00 → €90.00
Current: $243.60
Upside: n/a
Jan 19, 2021
Maintained: Hold
Price Target: $145 → $125
Current: $27.64
Upside: n/a
Aug 28, 2020
Maintained: Hold
Price Target: $52.84
Current: $18.76
Upside: n/a
Apr 25, 2019
Maintained: Buy
Price Target: $14
Current: $0.00001
Upside: n/a
Jun 1, 2018
Initiated Coverage: Buy
Price Target: $34
Current: $8.02
Upside: n/a